Risks and limits of Mikrobiom Basis

The question about risks and limits of the Mikrobiom Basis test cannot be answered from the provided context, which only covers DNA-related topics (e.g., APOE, ACTN3, HLA-DQB1) and a cortisol article. For a microbiome test, general limitations apply: Gut flora analysis is highly dependent on diet, medications, and daily variation, so a single test is only a snapshot. Many commercial providers base recommendations on poorly validated correlations or overstate the benefits of probiotics. Clinical guidelines for interpretation are often lacking. Without medical supervision, self-directed dietary changes can be risky (e.g., nutrient deficiencies). Evidence for personalized microbiome interventions is still weak. Therefore, caution is warranted: results should be seen as orientation, not a medical diagnosis.